Free Trial

Connor Clark & Lunn Investment Management Ltd. Raises Stock Position in CME Group Inc. (NASDAQ:CME)

CME Group logo with Finance background

Connor Clark & Lunn Investment Management Ltd. raised its position in CME Group Inc. (NASDAQ:CME - Free Report) by 4.1% during the third quarter, according to its most recent filing with the SEC. The firm owned 93,444 shares of the financial services provider's stock after purchasing an additional 3,721 shares during the period. Connor Clark & Lunn Investment Management Ltd.'s holdings in CME Group were worth $20,618,000 as of its most recent filing with the SEC.

Other institutional investors also recently modified their holdings of the company. PineStone Asset Management Inc. increased its holdings in shares of CME Group by 137.6% during the second quarter. PineStone Asset Management Inc. now owns 2,260,644 shares of the financial services provider's stock valued at $444,443,000 after acquiring an additional 1,309,097 shares in the last quarter. Assenagon Asset Management S.A. increased its holdings in CME Group by 577.9% during the 2nd quarter. Assenagon Asset Management S.A. now owns 645,330 shares of the financial services provider's stock worth $126,872,000 after purchasing an additional 550,133 shares in the last quarter. Ameriprise Financial Inc. grew its holdings in CME Group by 11.3% during the second quarter. Ameriprise Financial Inc. now owns 5,283,196 shares of the financial services provider's stock worth $1,038,676,000 after buying an additional 537,758 shares in the last quarter. International Assets Investment Management LLC raised its holdings in shares of CME Group by 21,465.5% in the third quarter. International Assets Investment Management LLC now owns 485,871 shares of the financial services provider's stock valued at $1,072,070,000 after purchasing an additional 483,618 shares during the last quarter. Finally, Baillie Gifford & Co. bought a new position in shares of CME Group during the 3rd quarter worth approximately $79,692,000. 87.75% of the stock is owned by institutional investors.

Insider Activity at CME Group

In other CME Group news, insider Timothy Francis Mccourt sold 1,374 shares of CME Group stock in a transaction on Monday, October 28th. The shares were sold at an average price of $227.12, for a total transaction of $312,062.88. Following the completion of the transaction, the insider now directly owns 7,275 shares of the company's stock, valued at $1,652,298. The trade was a 15.89 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Bryan T. Durkin sold 7,593 shares of CME Group stock in a transaction on Friday, August 30th. The stock was sold at an average price of $214.59, for a total value of $1,629,381.87. Following the sale, the director now owns 55,607 shares of the company's stock, valued at approximately $11,932,706.13. This trade represents a 12.01 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 15,621 shares of company stock worth $3,441,063. 0.30% of the stock is owned by insiders.

Wall Street Analyst Weigh In

A number of equities research analysts have recently commented on CME shares. Deutsche Bank Aktiengesellschaft lowered their target price on CME Group from $227.00 to $226.00 and set a "hold" rating on the stock in a research note on Monday, November 11th. Keefe, Bruyette & Woods upped their price objective on CME Group from $212.00 to $213.00 and gave the company a "market perform" rating in a research note on Thursday, July 25th. Oppenheimer boosted their target price on CME Group from $245.00 to $258.00 and gave the company an "outperform" rating in a research note on Thursday, October 24th. Bank of America lifted their price objective on CME Group from $177.00 to $180.00 and gave the stock an "underperform" rating in a report on Thursday, October 3rd. Finally, TD Cowen initiated coverage on shares of CME Group in a research report on Thursday, September 26th. They set a "hold" rating and a $221.00 target price for the company. Four analysts have rated the stock with a sell rating, seven have assigned a hold rating and four have issued a buy rating to the company's stock. Based on data from MarketBeat, the company currently has an average rating of "Hold" and an average price target of $224.47.

Check Out Our Latest Research Report on CME

CME Group Trading Up 0.2 %

Shares of NASDAQ:CME traded up $0.42 during midday trading on Thursday, hitting $228.42. 134,356 shares of the stock traded hands, compared to its average volume of 1,905,224. The business's 50 day moving average is $223.21 and its two-hundred day moving average is $210.81. The stock has a market capitalization of $82.31 billion, a PE ratio of 23.97, a P/E/G ratio of 5.30 and a beta of 0.55. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.09. CME Group Inc. has a one year low of $190.70 and a one year high of $230.74.

CME Group (NASDAQ:CME - Get Free Report) last released its earnings results on Wednesday, October 23rd. The financial services provider reported $2.68 earnings per share for the quarter, topping analysts' consensus estimates of $2.65 by $0.03. CME Group had a net margin of 57.34% and a return on equity of 13.39%. The firm had revenue of $1.58 billion for the quarter, compared to the consensus estimate of $1.59 billion. During the same period in the prior year, the firm earned $2.25 EPS. The company's revenue was up 18.4% compared to the same quarter last year. As a group, research analysts forecast that CME Group Inc. will post 10.22 earnings per share for the current year.

CME Group Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, December 27th. Stockholders of record on Monday, December 9th will be paid a $1.15 dividend. The ex-dividend date is Monday, December 9th. This represents a $4.60 dividend on an annualized basis and a dividend yield of 2.01%. CME Group's dividend payout ratio is presently 48.37%.

CME Group Profile

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Recommended Stories

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

→ My #1 Pre IPO Trade for 2025 – NAME and TICKER (From Wyatt Investment Research) (Ad)

Should you invest $1,000 in CME Group right now?

Before you consider CME Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CME Group wasn't on the list.

While CME Group currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Beginners Guide To Retirement Stocks Cover

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

’Best Report in 2 Years’: NVIDIA Earnings Crushes Expectations Again
Palantir and the NASDAQ 100: What’s the Next Big Stock Swing for This AI Giant?
Rocket Lab Stock Explodes Higher—What’s Next for This Space Pioneer?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines